Tetratricopeptide repeat domain 36 protects renal tubular cells from cisplatin-induced apoptosis potentially via maintaining mitochondrial homeostasis. (June 2022)

• Record Type: Journal Article
• Authors: Yan, Xin; Tian, Dayu; Peng, Rui; Chen, Lei; He, Qingling; Zhou, Qin; Li, Qianyin
• Is Part Of: Tissue & cell. Volume 76(2022)
• Publication Date: 2022-06
• Subjects: TTC36 -- Cisplatin -- Apoptosis -- Mitochondria; Cytology -- Periodicals; 571.5
• DOI: 10.1016/j.tice.2022.101749
• Languages: English
• ISSNs: 0040-8166

Abstract

Highlights: The expression of TTC36 was reduced in acute kidney injury. TTC36 protected HK2 cells against cisplatin-induced apoptosis. The mitochondrial homeostasis was maintained by TTC36. Abstract: The apoptosis of proximal tubule epithelial cells (PTECs) is a critical event of acute kidney injury (AKI). Tetratricopeptide repeat domain 36 (TTC36) with three tetratricopeptide repeats is evolutionarily conserved across mammals, which functions as a chaperone for heat shock protein 70. We have revealed that TTC36 is specifically expressed in PTECs in our previous work. There are few studies about the role of TTC36 in AKI. In this study, we observed that TTC36 was obviously down-regulated in a mouse model of acute kidney injury established by ischemia/reperfusion and its expression was negatively related to the degree of kidney injury. In addition, TTC36 protected HK2 cells against cisplatin-induced apoptosis. Moreover, we discovered the mechanism that TTC36 mitigated cisplatin-triggered mitochondrial disorder via partially sustaining the membrane potential of mitochondria and mitochondrial autophagy-related gene expression. Collectively, these results suggested that TTC36 plays a protective role in the cisplatin-induced apoptosis of renal tubular cells through maintaining the mitochondrial potential and mitochondrial autophagy-related genes' expression to some extent. These observations highlight the essential role of TTC36 in regulating PTEC apoptosis and imply TTC36/mitochondrial homeostasis axis as a potential target for the therapeutic intervention in AKI.